Medicare Benefits Schedule - Note TN.8.234

-       Not for use in patients with a type 3 transformation zone.

-       A second ablative treatment for a HSIL (CIN2/3) should NOT be performed (an excisional treatment is indicated in this situation).

-       Treatment of high-grade lesions (CIN 2/3) in an immunocompromised patients should be by excisional methods only.

Related Items: 35644 35645

• Previous - Note TN.8.233
• Next - Note TN.8.235

Multiple Operation Rule

Cervix, ablation by electrocoagulation diathermy, laser or cryotherapy, with colposcopy, including any local anaesthesia and biopsies, for previously biopsy confirmed HSIL (CIN 2/3) in a patient with a Type 1 or 2 (completely visible) transformation zone, if there is:
(a) no evidence of invasive or glandular disease; and
(b) no discordance between cytology and previous histology;
not being a service associated with a service to which item 35647 or 35648 applies 

(Anaes.)

Fee: $224.15 Benefit: 75% = $168.15 85% = $190.55

(See para TN.8.45, TN.8.234 of explanatory notes to this Category)

Multiple Operation Rule

Cervix, ablation by electrocoagulation diathermy, laser or cryotherapy, with colposcopy, including any local anaesthesia or biopsies, in conjunction with ablative therapy of additional areas of biopsy proven high grade intraepithelial lesions of one or more sites of the vagina, vulva, urethra or anus, for previously biopsy confirmed HSIL (CIN2/3) in a patient with a Type 1 of 2 (completely visible) transformation zone, if there is:
(a) no evidence of invasive or glandular disease; and
(b) no discordance between cytology and previous histology;
not being a service associated with a service to which item 35647 or 35648 applies 

(Anaes.)

Fee: $350.80 Benefit: 75% = $263.10 85% = $298.20

(See para TN.8.45, TN.8.234 of explanatory notes to this Category)